• Cencora swung to GAAP diluted earnings of $2.71 per share in fourth-quarter FY26 from a year-earlier loss.
• Quarterly revenue rose 6% year over year to $88.35 billion.
• FY26 GAAP diluted earnings more than doubled to $17.95 per share, while revenue increased 5% to $337.4 billion.
• The company signed a definitive agreement to acquire American Oncology Network, expanding its oncology platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cencora Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261103460200) on November 04, 2026, and is solely responsible for the information contained therein.